Potential biomarker of metformin action

Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms

(2013) Shaodong Guo   JOURNAL OF ENDOCRINOLOGY

Activation of Basal Gluconeogenesis by Coactivator p300 Maintains Hepatic Glycogen Storage

(2013) Ling He et al.   MOLECULAR ENDOCRINOLOGY

Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis

(2012) Ling He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis

(2010) Ronan Roussel   ARCHIVES OF INTERNAL MEDICINE

Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure

(2010) David Aguilar et al.   Circulation-Heart Failure

Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action

(2010) M. Takashima et al.   DIABETES

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

(2009) Ling He et al.   CELL

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16

(2009) G. W.D. Landman et al.   DIABETES CARE

Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure

(2008) Susheel Gundewar et al.   CIRCULATION RESEARCH

A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange

(2008) Yi Liu et al.   NATURE

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents

(2008) Kristen J Nadeau et al.   PEDIATRIC DIABETES